Adiponectin Activates the AMPK Signaling Pathway to Regulate Lipid Metabolism in Bovine Hepatocytes

Hui Chen,Liang Zhang,Xinwei Li,Xiaobing Li,Guoquan Sun,Xue Yuan,Liancheng Lei,Juxiong Liu,Liheng Yin,Qinghua Deng,Jianguo Wang,Zhaoxi Liu,Wentao Yang,Zhe Wang,Hui Zhang,Guowen Liu
DOI: https://doi.org/10.1016/j.jsbmb.2013.08.013
IF: 5.011
2013-01-01
The Journal of Steroid Biochemistry and Molecular Biology
Abstract:Adiponectin (Ad) plays a crucial role in hepatic lipid metabolism. However, the regulating mechanism of hepatic lipid metabolism by Ad in dairy cows is unclear. Hepatocytes from a newborn female calf were cultured in vitro and treated with different concentrations of Ad and BML-275 (an AMPKα inhibitor). The results showed that Ad significantly increased the expression of two Ad receptors. Furthermore, the phosphorylation and activity of AMPKα, as well as the expression levels and transcriptional activity of peroxisome proliferator activated receptor-α (PPARα) and its target genes involved in lipid oxidation, showed a corresponding trend of upregulation. However, the expression levels and transcriptional activity of sterol regulatory element binding protein 1c (SREBP-1c) and carbohydrate-responsive element-binding protein (ChREBP) decreased in a similar manner. When BML-275 was added, the p-AMPKα level as well as the expression and activity of PPARα and its target genes were significantly decreased. However, the expression levels of SREBP-1c, ChREBP and their target genes showed a trend of upregulation. Furthermore, the triglyceride (TG) content was significantly decreased in the Ad-treated groups. These results indicate that Ad activates the AMPK signaling pathway and mediates lipid metabolism in bovine hepatocytes cultured in vitro by promoting lipid oxidation, suppressing lipid synthesis and reducing hepatic lipid accumulation.
What problem does this paper attempt to address?